BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 38734900)

  • 1. Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques.
    Nakamura-Hoshi M; Ishii H; Nomura T; Nishizawa M; Hau TTT; Kuse N; Okazaki M; Ainai A; Suzuki T; Hasegawa H; Yoshida T; Yonemitsu K; Suzaki Y; Ami Y; Yamamoto H; Matano T
    Mol Ther; 2024 May; ():. PubMed ID: 38734900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
    Tu JJ; King E; Maksimova V; Smith S; Macias R; Cheng X; Vegesna T; Yu L; Ratner L; Green PL; Niewiesk S; Richner JM; Panfil AR
    J Virol; 2024 Feb; 98(2):e0162323. PubMed ID: 38193692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1 Proliferation after CD8
    Nakamura-Hoshi M; Nomura T; Nishizawa M; Hau TTT; Yamamoto H; Okazaki M; Ishii H; Yonemitsu K; Suzaki Y; Ami Y; Matano T
    Microbiol Spectr; 2023 Aug; 11(4):e0151823. PubMed ID: 37367230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
    Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
    Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques.
    Dezzutti CS; Frazier DE; Olsen RG
    Dev Biol Stand; 1990; 72():287-96. PubMed ID: 2178125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
    Hakoda E; Machida H; Tanaka Y; Morishita N; Sawada T; Shida H; Hoshino H; Miyoshi I
    Int J Cancer; 1995 Feb; 60(4):567-70. PubMed ID: 7829272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Cynomolgus Macaque Model of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Direct Inoculation of Adult T-Cell Leukemia Patient-Derived Cell Lines for HTLV-1 Infection.
    Urano E; Ueda K; Higuchi M; Furukawa M; Okamura T; Tanaka Y; Yasutomi Y
    J Virol; 2022 Nov; 96(22):e0133922. PubMed ID: 36314828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.
    Curtis AD; Saha PT; Dennis M; Berendam SJ; Ramasubramanian P; Cross KA; Alam SM; Ferrari G; Kozlowski PA; Fouda GG; Hudgens MG; Van Rompay KKA; Pollara J; Permar SR; De Paris K
    mSphere; 2022 Feb; 7(1):e0083921. PubMed ID: 35196125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
    Dezzutti CS; Frazier DE; Lafrado LJ; Olsen RG
    J Med Primatol; 1990; 19(3-4):305-16. PubMed ID: 2172541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-infection immunodeficiency virus control by neutralizing antibodies.
    Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques.
    Pahar B; Gray W; Fahlberg M; Grasperge B; Hunter M; Das A; Mabee C; Aye PP; Schiro F; Hensley K; Ratnayake A; Goff K; LaBranche C; Shen X; Tomaras GD; DeMarco CT; Montefiori D; Kissinger P; Marx PA; Traina-Dorge V
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
    Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
    J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Production of HTLV-II env protein and its suppressive effect on infection].
    Kawamura N
    Hokkaido Igaku Zasshi; 1995 Jul; 70(4):635-47. PubMed ID: 7590608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL).
    Tanaka Y; Tanaka R; Imaizumi N; Mizuguchi M; Takahashi Y; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Masuzaki H; Fukushima T
    Front Immunol; 2022; 13():921606. PubMed ID: 36177005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.